CHRONIC HEPATITIS D INFECTION
Clinical trials for CHRONIC HEPATITIS D INFECTION explained in plain language.
Never miss a new study
Get alerted when new CHRONIC HEPATITIS D INFECTION trials appear
Sign up with your email to follow new studies for CHRONIC HEPATITIS D INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First look at how kidneys handle promising hepatitis d treatment
Knowledge-focused CompletedThis early-stage study tested how the hepatitis D drug bulevirtide behaves in people with different levels of kidney function. Researchers gave the drug to 41 people, some with healthy kidneys and some with impaired kidney function. They measured how much drug got into the blood,…
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test hepatitis drug safety in people with liver problems
Knowledge-focused CompletedThis early-stage study aimed to understand how liver function affects the way the body processes bulevirtide, a medication for hepatitis D. Researchers compared 74 participants—some with healthy livers and some with impaired liver function—to measure drug levels in the blood and …
Matched conditions: CHRONIC HEPATITIS D INFECTION
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC